These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21380806)

  • 1. Identification and evaluation of neutral sphingomyelinase 2 inhibitors.
    Lee DH; Kim SH; Ahn KH; Kim SK; Choi JM; Ji JE; Won JH; Park YH; Lim C; Kim S; Kim DK
    Arch Pharm Res; 2011 Feb; 34(2):229-36. PubMed ID: 21380806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of neutral sphingomyelinase 2 from bovine brain and its calcium-dependent activation.
    Kim SK; Ahn KH; Jeon HJ; Lee DH; Jung SY; Jung KM; Kim DK
    J Neurochem; 2010 Feb; 112(4):1088-97. PubMed ID: 19968763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase.
    Luberto C; Hassler DF; Signorelli P; Okamoto Y; Sawai H; Boros E; Hazen-Martin DJ; Obeid LM; Hannun YA; Smith GK
    J Biol Chem; 2002 Oct; 277(43):41128-39. PubMed ID: 12154098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutral sphingomyelinase 2 induces dopamine uptake through regulation of intracellular calcium.
    Kim SK; Ahn KH; Ji JE; Choi JM; Jeon HJ; Jung SY; Jung KM; Kim DK
    Cell Signal; 2010 May; 22(5):865-70. PubMed ID: 20096352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein C-I induces apoptosis in human aortic smooth muscle cells via recruiting neutral sphingomyelinase.
    Kolmakova A; Kwiterovich P; Virgil D; Alaupovic P; Knight-Gibson C; Martin SF; Chatterjee S
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):264-9. PubMed ID: 14670935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of novel phosphate ester analogs as neutral sphingomyelinase inhibitors.
    Imagawa H; Oda M; Takemoto T; Yamauchi R; Yoshikawa T; Yamamoto H; Nishizawa M; Takahashi H; Hashimoto M; Yabiku K; Nagahama M; Sakurai J
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3868-71. PubMed ID: 20627555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism.
    Marchesini N; Luberto C; Hannun YA
    J Biol Chem; 2003 Apr; 278(16):13775-83. PubMed ID: 12566438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe
    Lallemand T; Rouahi M; Swiader A; Grazide MH; Geoffre N; Alayrac P; Recazens E; Coste A; Salvayre R; Nègre-Salvayre A; Augé N
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1479-1492. PubMed ID: 29794115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neutral sphingomyelinase-2 is involved in angiogenic signaling triggered by oxidized LDL.
    Camaré C; Augé N; Pucelle M; Saint-Lebes B; Grazide MH; Nègre-Salvayre A; Salvayre R
    Free Radic Biol Med; 2016 Apr; 93():204-16. PubMed ID: 26855418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties.
    Figuera-Losada M; Stathis M; Dorskind JM; Thomas AG; Bandaru VV; Yoo SW; Westwood NJ; Rogers GW; McArthur JC; Haughey NJ; Slusher BS; Rojas C
    PLoS One; 2015; 10(5):e0124481. PubMed ID: 26010541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of three competitive inhibitors for membrane-associated, Mg2+-dependent and neutral 60 kDa sphingomyelinase activity.
    Kim SK; Jung SM; Ahn KH; Jeon HJ; Lee DH; Jung KM; Jung SY; Kim DK
    Arch Pharm Res; 2005 Aug; 28(8):923-9. PubMed ID: 16178418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase.
    Mondal S; Mandal C; Sangwan R; Chandra S; Mandal C
    Mol Cancer; 2010 Sep; 9():239. PubMed ID: 20836852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a sphingomyelinase activity in Saccharomyces cerevisiae.
    Ella KM; Qi C; Dolan JW; Thompson RP; Meier KE
    Arch Biochem Biophys; 1997 Apr; 340(1):101-10. PubMed ID: 9126282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docosahexaenoic acid down-regulates phenobarbital-induced cytochrome P450 2B1 gene expression in rat primary hepatocytes via the sphingomyelinase/ceramide pathway.
    Lu CY; Li CC; Liu KL; Tsai CW; Lii CK; Chen HW
    J Nutr Biochem; 2010 Apr; 21(4):338-44. PubMed ID: 19427778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A signaling cascade mediated by ceramide, src and PDGFRβ coordinates the activation of the redox-sensitive neutral sphingomyelinase-2 and sphingosine kinase-1.
    Cinq-Frais C; Coatrieux C; Grazide MH; Hannun YA; Nègre-Salvayre A; Salvayre R; Augé N
    Biochim Biophys Acta; 2013 Aug; 1831(8):1344-56. PubMed ID: 23651497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceramide/sphingomyelin cycle involvement in gentamicin-induced cochlear hair cell death.
    Chi le NU; Tabuchi K; Nakamagoe M; Nakayama M; Nishimura B; Hara A
    Arch Toxicol; 2015 Mar; 89(3):415-21. PubMed ID: 24798086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol-3,5-Bisphosphate is a potent and selective inhibitor of acid sphingomyelinase.
    Kölzer M; Arenz C; Ferlinz K; Werth N; Schulze H; Klingenstein R; Sandhoff K
    Biol Chem; 2003 Sep; 384(9):1293-8. PubMed ID: 14515991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of human nSMase2 reveals an interdomain allosteric activation mechanism for ceramide generation.
    Airola MV; Shanbhogue P; Shamseddine AA; Guja KE; Senkal CE; Maini R; Bartke N; Wu BX; Obeid LM; Garcia-Diaz M; Hannun YA
    Proc Natl Acad Sci U S A; 2017 Jul; 114(28):E5549-E5558. PubMed ID: 28652336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An obligate role for membrane-associated neutral sphingomyelinase activity in orienting chemotactic migration of human neutrophils.
    Sitrin RG; Sassanella TM; Petty HR
    Am J Respir Cell Mol Biol; 2011 Feb; 44(2):205-12. PubMed ID: 20378749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel inhibitor of bacterial sphingomyelinase, SMY-540, developed based on three-dimensional structure analysis.
    Oda M; Imagawa H; Kato R; Yabiku K; Yoshikawa T; Takemoto T; Takahashi H; Yamamoto H; Nishizawa M; Sakurai J; Nagahama M
    J Enzyme Inhib Med Chem; 2014 Jun; 29(3):303-10. PubMed ID: 23488740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.